Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
The Long Run with Luke Timmerman
Exploring T-cell Engagers and the Balancing Act of Immune Cell Activation
Exploring the mechanism of action of bi-specific antibodies targeting CD19 and CD3, facilitating T-cell mediated killing of tumor cells while highlighting the hurdles in precise immune activation for effective therapy.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
